Liu Wen Tao 4
4 · Cellular Biomedicine Group, Inc. · Filed Apr 28, 2020
Insider Transaction Report
Form 4
Liu Wen Tao (Steve)
DirectorCEO
Transactions
- Award
Non-qualified stock option (right to buy)
2020-04-25+6,348→ 6,348 totalExercise: $14.65From: 2021-04-23Exp: 2030-04-26→ Common stock (6,348 underlying)
Footnotes (1)
- [F1]This option becomes exercisable and fully vests on April 23, 2021.